Shanghai High Myopia Study for Adults

Last updated: February 20, 2018
Sponsor: Shanghai Eye Disease Prevention and Treatment Center
Overall Status: Active - Recruiting

Phase

N/A

Condition

Eye Disorders/infections

Myopia

Treatment

N/A

Clinical Study ID

NCT03446300
YFZX2018002
  • Ages 18-100
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

High myopia retinopathy has become the first cause of irreversible blindness and severe visual impairment in Chinese adults, in order to avoid the blind and visual impairment caused by high myopia retinopathy, it is very necessary to research the mechanism of early visual impairment to prevent and control damages. Our recent research found that the decreasing of macular retina vascular density and subfoveal choroidal thickness, the increasing of Beta Zone area in optic atrophy and the rising of glycosylated hemoglobin in high myopia patients were significantly related to visual impairment, which suggested that the source of visual impairment was the abnormal structure changes surrounding optic and fovea, but so far there is no related study. We will conduct a 5 years prospective cohort study in the population of 2420 high myopia and controls which have established in college student population, working population and aged more than 50 years old population, using the latest OCT-A and SS-OCT to measure macular retina vascular density, subfoveal choroidal thickness, Beta Zone area in optic atrophy, combined with the semiparametric mixed effects model, we will analysis the prediction index between fundus structure parameters, blood biochemical index and individual characteristics prediction to explore the public health management mode of early prevention and treatment during high myopia population.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • ≥18 years old; spherical equivalent refraction ≤-6.00D;

Exclusion

Exclusion Criteria:

  • a history of ocular or systemic diseases including congenital cataract and glaucoma;previous intraocular or refractive surgery;other evidence of retinal pathology

Study Design

Total Participants: 2000
Study Start date:
January 01, 2016
Estimated Completion Date:
December 31, 2020

Connect with a study center

  • Shanghai Eye Disease Prevention & Treatment Center

    Shanghai, Shanghai 200040
    China

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.